CWM
ABBV icon

CMH Wealth Management’s AbbVie ABBV Stock Holding History

CMH Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,023
Closed -$234K – 114
2025
Q4 		$234K Sell
1,023
-600
-37% -$137K 0.05% 52
2025
Q3 		$376K Sell
1,623
-3
-0.2% -$611 0.08% 51
2025
Q2 		$302K Buy
1,626
+22
+1% +$4.09K 0.07% 49
2025
Q1 		$336K Sell
1,604
-646
-29% -$126K 0.08% 47
2024
Q4 		$400K Sell
2,250
-4
-0.2% -$735 0.09% 48
2024
Q3 		$445K Hold
2,254
– – 0.1% 48
2024
Q2 		$387K Buy
+2,254
New +$373K 0.1% 46
2020
Q2 		– Sell
-25,838
Closed -$1.97M – 50
2020
Q1 		$1.97M Buy
25,838
+6,272
+32% +$534K 1.15% 40
2019
Q4 		$1.73M Buy
19,566
+2,205
+13% +$183K 0.89% 47
2019
Q3 		$1.31M Sell
17,361
-2,191
-11% -$150K 0.74% 48
2019
Q2 		$1.42M Buy
19,552
+46
+0.2% +$3.62K 0.83% 46
2019
Q1 		$1.57M Sell
19,506
-14,095
-42% -$1.15M 0.95% 46
2018
Q4 		$3.1M Buy
33,601
+900
+3% +$79.1K 1.87% 16
2018
Q3 		$3.11M Buy
32,701
+2,695
+9% +$256K 1.63% 19
2018
Q2 		$2.79M Buy
30,006
+4,246
+16% +$415K 1.6% 18
2018
Q1 		$2.36M Buy
25,760
+75
+0.3% +$8.24K 1.59% 18
2017
Q4 		$2.53M Buy
25,685
+30
+0.1% +$2.83K 1.67% 15
2017
Q3 		$2.32M Buy
25,655
+155
+0.6% +$11.8K 1.72% 18
2017
Q2 		$1.86M Buy
25,500
+305
+1% +$20.5K 1.48% 28
2017
Q1 		$1.62M Buy
+25,195
New +$1.58M 1.27% 33

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CMH Wealth Management's ABBV Position: Q1 2026 in Review

CMH Wealth Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 1,023 shares — an estimated $234K sold.

CMH Wealth Management first reported a position in ABBV in Q1 2017 and held it in 20 quarters. The position peaked at $3.11M in Q3 2018. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • CMH Wealth Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • CMH Wealth Management sold 1,023 AbbVie shares in Q1 2026, an estimated $234K.
  • CMH Wealth Management first reported a position in AbbVie in Q1 2017 and held it in 20 quarters.
  • CMH Wealth Management's AbbVie position peaked at $3.11M in Q3 2018.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on CMH Wealth Management's 13F filing for Q1 2026, filed 13 Apr 2026.